miR-221/222 promotes S-phase entry and cellular migration in control of basal-like breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The miR-221/222 cluster acts as an oncomiR in various cancers.
• It is implicated in promoting epithelial-to-mesenchymal transition (EMT) and tamoxifen resistance in breast cancer.
• The precise mechanisms of miR-221/222 in regulating breast cancer aggressiveness are not fully understood.

Purpose of the Study:

• To investigate the role and mechanisms of the miR-221/222 cluster in basal-like breast cancer (BLBC) aggressiveness.
• To determine the association between miR-221/222 expression and breast cancer subtypes.
• To elucidate the impact of miR-221/222 on cell cycle regulation and tumor suppressor gene expression.

Main Methods:

• Comparative analysis of miR-221/222 expression in invasive BLBC versus non-invasive luminal breast cancer cells.
• Utilized a patient microRNA dataset to confirm elevated miR-221/222 in BLBC.
• Employed miRNA inhibitors to assess effects on cell migration, invasion, and cell cycle.
• Performed proteomic analysis to identify downstream targets of miR-221/222.

Main Results:

• Significantly higher miR-221/222 expression was observed in highly invasive BLBC cells compared to luminal cells.
• Elevated miR-221/222 levels were confirmed in the BLBC subtype using patient data.
• Inhibition of miR-221/222 suppressed cellular migration, invasion, and G1/S cell cycle transition in BLBC cells.
• Proteomic analysis revealed that miR-221/222 down-regulates tumor suppressor genes SOCS1 and CDKN1B.

Conclusions:

• miR-221/222 is significantly upregulated in aggressive basal-like breast cancer.
• miR-221/222 promotes cell migration, invasion, and G1/S cell cycle transition in BLBC.
• The cluster targets tumor suppressor genes SOCS1 and CDKN1B, contributing to breast cancer aggressiveness.